Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CTSL | P07711 | 2/20 | 0.45 |
| ▸ | CTSB | P07858 | 2/20 | 0.45 |
| ▸ | CTSS | P25774 | 2/20 | 0.45 |
| ▸ | CTSK | P43235 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6255909 | 0.85 | SMN1; SMN2 (0.48) | NPC1RAB9AALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL13188795 | 0.83 | NPC1 (0.45) | NPC1RAB9AALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL3583239 | 0.82 | ALDH1A1 (0.47) | RAB9AALDH1A1MAPTHTT | |
| SCHEMBL25298888 | 0.82 | NPC1 (0.46) | NPC1RAB9AALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL13189129 | 0.81 | NPC1 (0.43) | NPC1RAB9AALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL7694380 | 0.81 | ALDH1A1 (0.62) | NPC1RAB9AALDH1A1LMNAKMT2A | |
| SCHEMBL9228433 | 0.81 | HTT (0.45) | NPC1RAB9AALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL19007844 | 0.80 | ALDH1A1 (0.58) | NPC1RAB9AALDH1A1LMNAKMT2A | |
| SCHEMBL5969412 | 0.80 | ALDH1A1 (0.53) | NPC1RAB9AALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL7358561 | 0.80 | SMN1; SMN2 (0.43) | NPC1RAB9AALDH1A1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170174622-A1 | METHOD FOR PRODUCING TRI-CARBOBENZOXY-ARGININE | KANEKA CORPORATION (JP) | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174622-A1 | METHOD FOR PRODUCING TRI-CARBOBENZOXY-ARGININE | ARG1, ARGLU1, PRMT1 | NPC1 1693/4885RAB9A 1295/4885ALDH1A1 3308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.